Abstract |
Experiments on rats with isadrine damage to the myocardium showed that when used for preventive-therapeutic purposes 18-dehydroglycyrrhizic acid ( glyderinine preparation) causes statistically significant prevention of a rise in the serum level of marker enzymes ( creatine phosphokinase, lactate dehydrogenase, aspartate aminotranspherase), prevents activation of lipid peroxidation, decrease of blood serum antioxidation activity and pathological changes in the content of glycogen and total lipids in the heart, it also improves the electrocardiographic parameters, reduces myocardial inflammatory edema. The results of the study show that glyderinine possesses a marked cardioprotective effect.
|
Authors | N U Zakirov, M I Aĭzimov, A G Kurmukov |
Journal | Eksperimental'naia i klinicheskaia farmakologiia
(Eksp Klin Farmakol)
1999 Mar-Apr
Vol. 62
Issue 2
Pg. 19-21
ISSN: 0869-2092 [Print] Russia (Federation) |
Vernacular Title | Kardioprotektornoe deĭstvie 18-degidroglitsirretovoĭ kisloty pri éksperimental'nom povrezhdenii miokarda. |
PMID | 10340122
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
Chemical References |
- 18-dehydroglycyrrhetic acid
- Adrenergic beta-Agonists
- Cardiovascular Agents
- Isoproterenol
- Glycyrrhetinic Acid
|
Topics |
- Adrenergic beta-Agonists
- Animals
- Cardiomyopathies
(chemically induced, drug therapy, metabolism, physiopathology)
- Cardiovascular Agents
(therapeutic use)
- Drug Evaluation, Preclinical
- Electrocardiography
(drug effects)
- Glycyrrhetinic Acid
(analogs & derivatives, therapeutic use)
- Isoproterenol
- Lipid Peroxidation
(drug effects)
- Male
- Rats
|